Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
PMID: 31116032 ·
Philip Urban, Roxana Mehran, Roisin Colleran, Dominick J Angiolillo, Robert A Byrne, Davide Capodanno, Thomas Cuisset, Donald Cutlip, Pedro Eerdmans, John Eikelboom, Andrew Farb, C Michael Gibson, John Gregson, Michael Haude, Stefan K James, Hyo-Soo Kim, Takeshi Kimura, Akihide Konishi, John Laschinger, Martin B Leon, P F Adrian Magee, Yoshiaki Mitsutake, Darren Mylotte, Stuart Pocock, Matthew J Price, Sunil V Rao, Ernest Spitzer, Norman Stockbridge, Marco Valgimigli, Olivier Varenne, Ute Windhoevel, Robert W Yeh, Mitchell W Krucoff, Marie-Claude Morice
Abstract
Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical decision-making. The Academic Research Consortium for High Bleeding Risk (ARC-HBR) is a collaboration among leading research organizations, regulatory authorities, and physician-scientists from the United States, Asia, and Europe focusing on percutaneo
Official Source
View on PubMed →Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.